Primo Biotechnology
About:
Primo aims at precision medicine and help the development of radioligand theranostics (RLT).
Website: https://primobt.com/en/
Top Investors: AVA Angels
Description:
Primo Biotechnology harnesses advanced molecular imaging and radiopharmaceutical science to provide precise clinical information via targeted radiopharmaceuticals. Primo Biotechnology aims to form a patient-centric healthcare model and establish doctor-patient relationships founded on trust towards conveying hope and happiness to all patients.
Total Funding Amount:
$6.5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Taipei, T'ai-pei, Taiwan
Founded Date:
2023-01-01
Contact Email:
contact(AT)primobt.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-06-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai